Intimation of Closure of Trading Window from 01st October 2026 till 48 hours after the declaration of the financial result of the Company for the quarter ended 30th September 2026 (Q2)

To To Date: September 25, 2026 Listing Compliance Department BSE Limited National Stock Exchange of India Limited, 1st Floor, New Trading Ring, Exchange Plaza, 5th Floor, Plot No. C/2, G Rotunda Building, P.J. Towers, Block, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai – 400001 Mumbai-400051 Scrip Code: 524824 Symbol: BALPHARMA Ref: ISIN - INE083D01012 Sub: Intimation of Closure of Trading Window for the quarter ending September 2026 Dear Sir/Madam, We wish to inform that pursuant to the Company's Code of Conduct for Prevention of Insider Trading and in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window of the Company will remain closed from October 01,2026 upto 48 hours after the declaration of the Financial Results of the Company for the second quarter ending on September 30,2026. Accordingly, all connected persons/designated persons and their immediate relatives are advised not to deal/ trade in any way in the securities of the Company during the aforesaid period of closure of trading window, The date of Board Meeting for announcement of the Financial Results shall be informed in due course. Please takes this intimation on your records Thanking You. For Bal Pharma Limited Shreepada ML Company Secretary and Compliance officer ICSI M No : A66681